Market LIVE
Published markets; coverage varies by country
Product profile · United States

BYLVAY

 ·  Patent Litigation & Settlement History ↓

IngredientODEVIXIBAT
Application typeNDA
Application215498
Product002
Dosage formCAPSULE
RouteORAL
Strength0.4MG
Approval date2021-07-20
Marketing statusPrescription
Status event—
ApplicantIPSEN
Product source

Current GenericRadar decision

Year2034
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typeDS_EQUIVALENT_PATENT
Anchor date2034-03-18
Patent anchor2034-03-18
Exclusivity anchor2026-07-20
Protection date2041-11-12
First Final ANDA—
Status event—

US9694018 c1/11 covers ALGS/PFIC; age/strength/form unrestricted. Hydrate/particle/PFIC tails retained.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
100116332031-11-08U U-3648NYU
English description not available.
———
100116332031-11-08U U-3186NYU
English description not available.
———
100116332031-11-08ORANGE_BOOK U-3186;U-3648NYU
English description not available.
———
100936972031-11-08U U-3648NYU
English description not available.
———
100936972031-11-08U U-3186NYU
English description not available.
———
100936972031-11-08ORANGE_BOOK U-3186;U-3648NYU
English description not available.
———
104871112031-11-08U U-3648NYU
English description not available.
———
104871112031-11-08U U-3186NYU
English description not available.
———
104871112031-11-08ORANGE_BOOK U-3186;U-3648NYU
English description not available.
———
109819522031-11-08U U-3648NNU
English description not available.
———
109819522031-11-08U U-3187NNU
English description not available.
———
109819522031-11-08U U-3649NNU
English description not available.
———
109819522031-11-08U U-3186NNU
English description not available.
———
109819522031-11-08ORANGE_BOOK U-3186;U-3187;U-3648;U-3649NNU
English description not available.
———
117320062031-11-08U U-3186NYU
English description not available.
———
117320062031-11-08U U-3648NYU
English description not available.
———
117320062031-11-08ORANGE_BOOK U-3186;U-3648NYU
English description not available.
———
121878122031-11-08U U-3648NNU
English description not available.
———
121878122031-11-08U U-3186NNU
English description not available.
———
121878122031-11-08ORANGE_BOOK U-3186;U-3648NNU
English description not available.
———
125457052031-11-08U U-3186NNU
English description not available.
———
125457052031-11-08U U-3648NNU
English description not available.
———
125457052031-11-08ORANGE_BOOK U-3186;U-3648NNU
English description not available.
———
96940182034-03-18U U-3186NYU
English description not available.
———
96940182034-03-18U U-3648NYU
English description not available.
———
96940182034-03-18ORANGE_BOOK U-3186;U-3648NYU
English description not available.
———
109750462039-06-20DS —NNDP
English description not available.
———
109750462039-06-20ORANGE_BOOK —NNDP
English description not available.
———
113651822039-06-20U U-3186NNU
English description not available.
———
113651822039-06-20U U-3648NNU
English description not available.
———
113651822039-06-20ORANGE_BOOK U-3186;U-3648NNU
English description not available.
———
118012262039-06-20DP —NNDP
English description not available.
———
118012262039-06-20ORANGE_BOOK —NNDP
English description not available.
———
118021152039-06-20DP —NNDP
English description not available.
———
118021152039-06-20ORANGE_BOOK —NNDP
English description not available.
———
120913942039-06-20DS —NNPROCESS
English description not available.
———
120913942039-06-20ORANGE_BOOK —NNPROCESS
English description not available.
———
125082342039-06-20U U-3648NNU
English description not available.
———
125082342039-06-20U U-3186NNU
English description not available.
———
125082342039-06-20ORANGE_BOOK U-3186;U-3648NNU
English description not available.
———
115835392041-11-12U U-3186NNU
English description not available.
———
115835392041-11-12ORANGE_BOOK U-3186NNU
English description not available.
———
124471562041-11-12U U-3186NNU
English description not available.
———
124471562041-11-12ORANGE_BOOK U-3186NNU
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
I-9182023-06-132026-06-13English description not available.NN——Source
I-9182023-06-132026-06-13English description not available.NN—
ODE-363 + ODE-436
Full coverage date: —
Source
NCE2021-07-202026-07-20English description not available.YY2026-07-20—Source
NCE2021-07-202026-07-20English description not available.YY2026-07-20
ODE-363 + ODE-436
Full coverage date: 2026-07-20
Source
ODE-3632021-07-202028-07-20English description not available.NN——Source
ODE-3632021-07-202028-07-20English description not available.NN—
ODE-363 + ODE-436
Full coverage date: —
Source
ODE-4362023-06-132030-06-13English description not available.NN——Source
ODE-4362023-06-132030-06-13English description not available.NN—
ODE-363 + ODE-436
Full coverage date: —
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (1)
TypeDateRoleBasisSource
ANNUAL_DECISION_RECHECK—ANCHOR_AND_TAILUS9694018 c1/11 covers ALGS/PFIC; age/strength/form unrestricted. Hydrate/particle/PFIC tails retained.Source
Decision history
CurrentYearStatusReviewAnchorJudged
Y2034DEEP_REVIEWFINAL2034-03-182026-10-17 20:32:21
N2034DEEP_REVIEWFINAL2034-03-182026-10-15 05:56:56
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.